搜索
Akoustis Technologies Ord Shs
AKTS添加自选
24.010USD
-0.800-3.22%
收盘 07-23 16:00（美东）报价延迟15分钟
1.22B总市值
亏损市盈率 TTM
关于 Akoustis Technologies Ord Shs 公司
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Akoustis Technologies Ord Shs简介
公司代码AKTS
公司名称Aktis Oncology Inc
上市日期Jan 09, 2026
CEORoden (Matthew)
员工数量117
证券类型Ordinary Share
年结日Jan 09
公司地址17 Drydock Avenue
城市BOSTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02210
电话13026587581
网址https://www.aktisoncology.com/
公司代码AKTS
上市日期Jan 09, 2026
CEORoden (Matthew)
Akoustis Technologies Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Arthur E. Geiss, Ph.D.
Mr. Arthur E. Geiss, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Jerry D. Neal, Ph.D.
Dr. Jerry D. Neal, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Ms. Jill K. Frizzley
Ms. Jill K. Frizzley
Independent Director
Independent Director
--
--
Mr. Matthew R. Kahn, CPA
Mr. Matthew R. Kahn, CPA
Independent Director
Independent Director
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board of Director
Chairman of the Board of Director
--
-100.00%
Ms. Shulamit Ron-Bigger, Ph.D.
Ms. Shulamit Ron-Bigger, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kyle D. Kuvalanka
Mr. Kyle D. Kuvalanka
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Arthur E. Geiss, Ph.D.
Mr. Arthur E. Geiss, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Jerry D. Neal, Ph.D.
Dr. Jerry D. Neal, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Ms. Jill K. Frizzley
Ms. Jill K. Frizzley
Independent Director
Independent Director
--
--
常见问题
Akoustis Technologies Ord Shs的前五大股东是谁？
Akoustis Technologies Ord Shs 的前五大股东如下：Mr. Matthew (Matt) Roden, Ph.D.
有多少机构持有Akoustis Technologies Ord Shs(AKTS)的股份？
截至2026Q1，共有195家机构持有Akoustis Technologies Ord Shs的股份，合计持有的股份价值约为27.52M，占公司总股份的51.47%。与2025Q4相比，机构持股有所增加，增幅为1127277.00。